-
Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies
Post on 4/17/19
-
RRD International Expands Clinical Pharmacology Capabilities
Post on 4/17/19
-
2019’s Best & Worst States for Children’s Health Care – WalletHub Study
Post on 4/17/19
-
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
Post on 4/16/19
-
Alteon Health Expands Hospitalist Care To Long-Time Health System Partners
Post on 4/16/19
-
Omni Ophthalmic Management Acquires Ludwick Eye Center
Post on 4/16/19
-
Baltimore Ravens Tony Jefferson to Visit Baltimore Medical System in Highlandtown
Post on 4/15/19
-
Rock Springs Capital Leads $11.2 Million For EIP Pharma
Post on 4/15/19
-
Paragon Biosciences Acquired By Catalent for $1.2 Billion
Post on 4/15/19
-
Novavax: I'll Take Capitulation And Despondency Before Hope
Post on 4/15/19
-
GlycoMimetics Announces Plans to Initiate Breast Cancer Trial to Evaluate GMI-1359
Post on 4/14/19
-
How to Maintain Flexibilty for Longterm Health
Post on 4/14/19
-
Rexahn Effects 1-for-12 Reverse Stock Split
Post on 4/14/19
-
Beltsville Based NextCure Readies IPO
Post on 4/14/19
-
ChoiceOne Urgent Care Partners with Coppermine Fieldhouse
Post on 4/11/19
-
Paragon Bioservices Celebrates Grand Opening of its World-Class Gene Therapy Biomanufacturing Facility
Post on 4/11/19
-
Orgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBio
Post on 4/11/19
-
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Post on 4/11/19
-
StageBio and Tox Path Specialists Merge
Post on 4/11/19
-
Rexahn Announces Reverse Stock Split
Post on 4/10/19
-
Merkle/HelloWorld Named a Strong Performer among Loyalty Technology Solutions
Post on 4/10/19
-
Rock Springs Capital and NEA Join $67M Series A2 For Inozyme Pharma
Post on 4/10/19
-
ACHF and Aetna Student Health Collaborate
Post on 4/15/19
-
Harvest Health & Recreation To Acquire CannaPharmacy
Post on 4/9/19
-
Ascentage Pharma Announces Clinical Collaboration with Junshi Bioscience
Post on 4/8/19
Health/Biotech
Connect with these Baltimore Professionals on LinkedIn
-
Edwin Warfield
Editor in Chief, Warfield Digital
Connect -
Jean Halle
Independent Consultant
Connect -
Larry Lichtenauer
President of Lawrence Howard & Associates
Connect -
Newt Fowler
Partner at Womble Carlyle, LLP
Connect -
David Crowley
Owner at Develop DC
Connect -
Carolyn Stinson
Stinson Marketing Group
Connect